Price $0.32 |
Market Cap
9.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
0.57
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-44.2K
|
FCF
-2.0
|
|
Op. Margin
-303.70%
|
Net Margin
-342.50%
|
ROE
-
|
ROI
-111.50%
|
|
ROA
-120.90%
|
EPS Growth
44.30%
|
Current Ratio
1.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| CYANOTECH CORP (CYAN) | $4.95 | - | - | 21.9M | Strong Buy |
| DURECT Corporation (DRRX) | $1.97 | - | - | 258.7M | Strong Buy |
| Biomerica, Inc. (BMRA) | $2.81 | - | - | 22.8M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.82 | - | - | 14.3M | Strong Buy |
| Aviragen Therapeutics Inc (AVIR) | $0.72 | - | - | 25.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
